[Characterisation of circulating microRNA-21 levels in patients with hypertrophic cardiomyopathy].
A J GudkovaV G DavidovaT G BezhanishviliS A PykoM I ZarayskiyPublished in: Terapevticheskii arkhiv (2020)
The level of circulating microRNA-21 is significantly in patients with HCM compared to control group. The maximum level of circulating microRNA-21 was detected in patients with symptomatic course of HCM at the age of 45 years.